Directory
>
Christopher Frankenfield
Christopher Frankenfield
Chief Financial Officer and Chief Operating Officer | Xilio Therapeutics, Inc.
United States
Christopher Frankenfield
Summary
Christopher Frankenfield is a seasoned executive with extensive experience in the legal and management consulting sectors. As the Chief Operating Officer at Xilio Therapeutics, he leverages his background in corporate law and governance to drive strategic initiatives and operational efficiency. With a career spanning over two decades, Christopher has held various leadership roles, including Chief Legal and Administrative Officer and Vice President of Corporate Legal Affairs, where he has been instrumental in mergers, acquisitions, and corporate strategy. He holds a Juris Doctor from the University of Virginia and a Bachelor's degree in Economics and Finance from the College of William & Mary. His expertise encompasses a broad range of areas including finance, due diligence, and venture capital, making him a versatile leader in the commercial physical research industry. Christopher has also contributed to academic discourse through publications in health care law, showcasing his commitment to thought leadership. His ability to navigate complex legal landscapes while fostering innovation sets him apart in his field.
Christopher Frankenfield
Work Experience
Chief Financial Officer and Chief Operating Officer at
Xilio Therapeutics, Inc.
August 2024 - Present
Chief Operating Officer at
Xilio Therapeutics, Inc.
August 2023 - August 2024
Chief Legal and Administrative Officer at
Xilio Therapeutics, Inc.
August 2022 - August 2023
Senior Vice President and General Counsel at
Xilio Therapeutics, Inc.
March 2021 - August 2022
Vice President, Corporate Legal Affairs at
Blueprint Medicines
July 2019 - March 2021
Senior Corporate Counsel at
Blueprint Medicines
July 2017 - July 2019
Corporate Counsel at
Blueprint Medicines
August 2015 - July 2017
Senior Associate at
Wilmer Cutler Pickering Hale and Dorr LLP
March 2010 - August 2015
Summer Associate at
Wilmer Cutler Pickering Hale and Dorr LLP
May 2008 - July 2008
Summer Associate at
Kilpatrick Townsend & Stockton LLP
May 2007 - July 2007
Associate - Advisory Practice (Dispute Analysis & Investigations) at
PwC
August 2004 - July 2006
Intern - Regulatory Department at
Amerigroup
May 2003 - August 2003
Intern - Marketing Department at
Dominion Enterprises
June 2002 - August 2002
Christopher Frankenfield
Education
University of Virginia School of Law, Jd
January 2006 - January 2009
The College of William & Mary, Ba
January 2000 - January 2004
Frequently Asked Questions about Christopher Frankenfield
What is Christopher Frankenfield email address?
Christopher Frankenfield's primary email address is *************@xiliotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Christopher Frankenfield work for?
Christopher Frankenfield is a Chief Financial Officer and Chief Operating Officer at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.
Where Christopher Frankenfield graduated from?
Christopher Frankenfield holds a degree in from University of Virginia School of Law.
How can I directly contact Christopher Frankenfield?
To contact Christopher Frankenfield directly, you can use the email address *************@xiliotx.com. Complete contact information is available upon registration with Muraena.
Who is Christopher Frankenfield?
Christopher Frankenfield is a seasoned executive with extensive experience in the legal and management consulting sectors. As the Chief Operating Officer at Xilio Therapeutics, he leverages his background in corporate law and governance to drive strategic initiatives and operational efficiency. With a career spanning over two decades, Christopher has held various leadership roles, including Chief Legal and Administrative Officer and Vice President of Corporate Legal Affairs, where he has been instrumental in mergers, acquisitions, and corporate strategy. He holds a Juris Doctor from the University of Virginia and a Bachelor's degree in Economics and Finance from the College of William & Mary. His expertise encompasses a broad range of areas including finance, due diligence, and venture capital, making him a versatile leader in the commercial physical research industry. Christopher has also contributed to academic discourse through publications in health care law, showcasing his commitment to thought leadership. His ability to navigate complex legal landscapes while fostering innovation sets him apart in his field.
Christopher`s contact details
*************@xiliotx.com
*************@blueprintmedicines.com
Colleagues
Senior Vice President, Corporate Development and Program Leadership
Senior Vice President Clinical Operations
Senior Vice President Tech Ops
Director
Chief Development Officer (CDO)
Vice President Clinical Science and Pharmacovigilance
Chief Medical Officer
Chief Scientific Officer
Founder and Chief Development Office